Old Web
English
Sign In
Acemap
>
Paper
>
RARE-45. ACTIVITY OF LAROTRECTINIB IN TRK FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS
RARE-45. ACTIVITY OF LAROTRECTINIB IN TRK FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS
2019
François Doz
Birgit Geoerger
Steven G. DuBois
Juneko E. Grilley-Olson
Cornelis M. van Tilburg
Antoine Italiano
Andrej Lissat
Hyoung Jin Kang
Makoto Tahara
Valentina Boni
Sébastien Perreault
Michael Capra
Shivani Nanda
Nicoletta Brega
Ariadna Holynskyj
David S. Ziegler
David S. Hong
David M. Hyman
Alexander Drilon
Keywords:
Medicine
Central nervous system
Trk receptor
Pathology
Cancer
disease progression
drug approval
Glioma
Fusion gene
Glioblastoma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]